Background With the rapid, global spread of severe acute respiratory syndrome coronavirus
2, hospitals have become inundated with patients suffering from coronavirus disease 2019 …

The recent outbreak of the corona virus disease (COVID-19) has had major global impact.
The relationship between severe acute respiratory syndrome coronavirus (SARS-CoV-2) …

Background: The novel coronavirus pandemic calls for a rapid adaptation of conventional
medical practices to meet the evolving needs of such vulnerable patients. People with …

Background: The management of coronavirus disease 2019 (COVID-19) in patients with
comorbid psychiatric disorders poses several challenges, especially regarding drug …

Abstract Purpose of Review To describe the presentation, etiologies, and suggested
management of post-acute COVID-19 neuropsychiatric symptoms. Recent Findings Over …

Objectives: To ascertain factors associated with worsening of psychiatric conditions during
the coronavirus disease 2019 (COVID-19) pandemic. Methods: This study anonymously …

Many psychiatric patients have been infected with COVID-19, and patients with COVID-19
may develop psychiatric symptoms after treatment with antiviral drugs. Given the tolerability …

As yet, no agents have been approved for the treatment of COVID-19, although several
experimental drugs are being used off licence. These may have serious adverse effects and …

Background: The coronavirus disease 2019 (COVID-19) pandemic and public health
measures that took place have led to concerns regarding mental health and receipt of …

Treatment with psychotropic medication may sometimes be jeopardised because of the
COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific …